Ionis Pharmaceuticals IONS Repayments of Secured Debt
Repayments of Secured Debt at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:RepaymentsOfSecuredDebt.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's repayments of secured debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's repayments of secured debt?
- Ionis Pharmaceuticals (IONS) reported repayments of secured debt of $44K in Q1 2026.
- How has Ionis Pharmaceuticals's repayments of secured debt changed year-over-year?
- Ionis Pharmaceuticals's repayments of secured debt increased by 4.8% year-over-year, from $42K to $44K.
- What does repayments of secured debt mean?
- Cash used to pay off debt backed by collateral.
- How do you interpret repayments of secured debt?
- Consistent repayment signals financial health and a reduction in the risk of asset seizure by creditors.
- How does repayments of secured debt compare across companies?
- Standard metric for companies with asset-backed financing arrangements.